Dong-hou O. Kim

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

First Exclusive Reconstruction of the B^{+}, B^{0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

First Exclusive Reconstruction of the B^{+}, B^{0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

Journal: Physical review letters

Published: August 07, 2025

Comparing anti-tau antibodies under clinical trials and their epitopes on tau pathologies.

Comparing anti-tau antibodies under clinical trials and their epitopes on tau pathologies.

Journal: Molecular neurodegeneration

Published: August 16, 2024

Neuronal MHC-I complex is destabilized by amyloid-β and its implications in Alzheimer's disease.

Neuronal MHC-I complex is destabilized by amyloid-β and its implications in Alzheimer's disease.

Journal: Cell & bioscience

Published: June 17, 2023

Probing Heavy Majorana Neutrinos and the Weinberg Operator through Vector Boson Fusion Processes in Proton-Proton Collisions at sqrt[s]=13 TeV.

Probing Heavy Majorana Neutrinos and the Weinberg Operator through Vector Boson Fusion Processes in Proton-Proton Collisions at sqrt[s]=13 TeV.

Journal: Physical review letters

Published: June 17, 2022

Tau acetylation at K280 regulates tau phosphorylation.

Tau acetylation at K280 regulates tau phosphorylation.

Journal: The International journal of neuroscience

Published: May 23, 2022

Monoclonal antibody Y01 prevents tauopathy progression induced by lysine 280-acetylated tau in cell and mouse models.

Monoclonal antibody Y01 prevents tauopathy progression induced by lysine 280-acetylated tau in cell and mouse models.

Journal: The Journal of clinical investigation

Published: November 08, 2021

Amphiregulin normalizes altered circuit connectivity for social dominance of the CRTC3 knockout mouse.

Amphiregulin normalizes altered circuit connectivity for social dominance of the CRTC3 knockout mouse.

Journal: Molecular psychiatry

Published: June 21, 2021

TLQP-21 mediated activation of microglial BV2 cells promotes clearance of extracellular fibril amyloid-β.

TLQP-21 mediated activation of microglial BV2 cells promotes clearance of extracellular fibril amyloid-β.

Journal: Biochemical and biophysical research communications

Published: December 30, 2019

Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer's disease.

Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer's disease.

Journal: Aging cell

Published: December 26, 2018

V232M substitution restricts a distinct O-glycosylation of PLD3 and its neuroprotective function.

V232M substitution restricts a distinct O-glycosylation of PLD3 and its neuroprotective function.

Journal: Neurobiology of disease

Published: December 24, 2018

Ouabain activates transcription factor EB and exerts neuroprotection in models of Alzheimer's disease.

Ouabain activates transcription factor EB and exerts neuroprotection in models of Alzheimer's disease.

Journal: Molecular and cellular neurosciences

Published: August 20, 2018

Small-molecule drug screening identifies drug Ro 31-8220 that reduces toxic phosphorylated tau in Drosophila melanogaster.

Small-molecule drug screening identifies drug Ro 31-8220 that reduces toxic phosphorylated tau in Drosophila melanogaster.

Journal: Neurobiology of disease

Published: July 11, 2018

Showing 1-12 of 29

Last Updated: 09/26/2026